.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Cipla
Argus Health
Queensland Health
Johnson and Johnson
Dow
US Army
Covington
Federal Trade Commission
McKesson

Generated: December 16, 2017

DrugPatentWatch Database Preview

US Patents With Foreign Priority to United Kingdom Patent: 9506126

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Shire Dev LlcFOSRENOLlanthanum carbonatePOWDER;ORAL204734-001Sep 24, 2014RXYesNo► Subscribe► SubscribeYTO REDUCE SERUM PHOSPHATE IN PATIENTS WITH END STAGE RENAL DISEASE
Shire Dev LlcFOSRENOLlanthanum carbonatePOWDER;ORAL204734-002Sep 24, 2014RXYesYes► Subscribe► SubscribeYTO REDUCE SERUM PHOSPHATE IN PATIENTS WITH END STAGE RENAL DISEASE
Shire LlcFOSRENOLlanthanum carbonateTABLET, CHEWABLE;ORAL021468-001Oct 26, 2004DISCNNoNo► Subscribe► SubscribeYREDUCTION OF SERUM PHOSPHATE
Shire LlcFOSRENOLlanthanum carbonateTABLET, CHEWABLE;ORAL021468-002Oct 26, 2004ABRXYesNo► Subscribe► SubscribeYREDUCTION OF SERUM PHOSPHATE
Shire LlcFOSRENOLlanthanum carbonateTABLET, CHEWABLE;ORAL021468-003Nov 23, 2005ABRXYesNo► Subscribe► SubscribeYREDUCTION OF SERUM PHOSPHATE
Shire LlcFOSRENOLlanthanum carbonateTABLET, CHEWABLE;ORAL021468-004Nov 23, 2005ABRXYesYes► Subscribe► SubscribeYREDUCTION OF SERUM PHOSPHATE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist